[Detection of BCR/ABL Fusion Gene and ASS1 Gene Deletion by Using Tricolor Dual-fusion Probe].


Journal

Zhongguo shi yan xue ye xue za zhi
ISSN: 1009-2137
Titre abrégé: Zhongguo Shi Yan Xue Ye Xue Za Zhi
Pays: China
ID NLM: 101084424

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 28 8 2020
Statut: ppublish

Résumé

To analyze the significance of various abnormal signal patterns appreared in CML and B-ALL patients by using BCR/ABL/ASS1 tricolor dual-fusion probe, and to explore its application value in detecting BCR/ABL fusion gene and ASS1 gene deletion. 50 newly diagnosed CML patients and 50 newly diagnosed B-ALL patients were detected by fluorescence in situ hybridization (FISH) with BCR/ABL/ASS1 tricolor dual-fusion probe. Meanwhile, karyotype analysis was performed on all the patients using the 24 hours short-term culture and R-banding. Among the 50 CML patients, Ph Tricolor dual-fusion FISH probe for detecting BCR/ABL fusion gene and ASS1 gene deletion is simple, rapid, sensitive and stable. It can detect various forms of molecular fusion and avoid the false positive results due to coincidental overlap of signals generated by D-FISH probe and ES-FISH probe. In addition, this detection method not only can directly observe the presence or absence of ASS1 gene deletion, but also improve the reliability of the positive results of newly diagnosed BCR/ABL fusion gene and accuracy of monitoring results of minimal residual disease for the subsequent visit. 应用三色双融合探针检测BCR-ABL融合基因及ASS1基因缺失. 分析BCR/ABL/ASS1三色双融合探针在CML和B-ALL所出现的各种异常信号模式的意义,并探讨其在检测BCR/ABL融合基因及ASS1基因缺失中的应用价值. 分别对50例初诊CML患者和50例初诊B-ALL患者采用BCR/ABL/ASS1三色双融合探针进行荧光原位杂交(FISH)检测,同时对所有病例应用24 h短期培养法R显带后进行染色体核型分析. 50例CML患者中,49例Ph 应用三色双融合FISH探针检测BCR/ABL融合基因及ASS1基因缺失,具有简单、快速、灵敏、稳定的特点,能够检测多种形式的分子融合,可很好地避免D-FISH探针及ES-FISH探针因信号随机重叠导致的假阳性结果。该检测方法不但可以直接观察有无ASS1基因的缺失,而且还能提高初诊BCR/ABL融合基因阳性结果的可靠性及复诊监测微小残留病结果的准确性.

Autres résumés

Type: Publisher (chi)
应用三色双融合探针检测BCR-ABL融合基因及ASS1基因缺失.

Identifiants

pubmed: 32798385
pii: 1009-2137(2020)04-1115-08
doi: 10.19746/j.cnki.issn.1009-2137.2020.04.006
doi:

Substances chimiques

Fusion Proteins, bcr-abl EC 2.7.10.2

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1115-1122

Auteurs

Zhen-Hao Zhang (ZH)

Department of Hematology, Peking University Third Hospital, Beijing 100191,China.

Yan-Fang Wang (YF)

Department of Hematology, Peking University Third Hospital, Beijing 100191,China.

Miao Wang (M)

Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China.

Fei Dong (F)

Department of Hematology, Peking University Third Hospital, Beijing 100191,China.

Wei Wan (W)

Department of Hematology, Peking University Third Hospital, Beijing 100191,China.

Xiao-Yan Ke (XY)

Department of Hematology, Peking University Third Hospital, Beijing 100191,China.

Hong-Mei Jing (HM)

Department of Hematology, Peking University Third Hospital, Beijing 100191,China,E-mail: hongmeijing@medmail.com.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH